Professional Insight
Buying medical equipment is only the beginning. Its real public-health value depends on appropriate specification, procurement, commissioning, maintenance, utilisation, quality assurance and lifecycle governance.
Medical equipment is one of the most visible investments in a health system. A new laboratory analyser, imaging system or critical-care device can represent better diagnostic capacity, faster clinical decisions and improved access to care.
Yet procurement by itself does not create those outcomes.
A machine delivers public-health value only when it is appropriate for the service, correctly specified, installed in a ready facility, operated by trained personnel, supported with consumables and maintenance, monitored for performance and replaced at the right time.
This distinction matters because health systems can succeed in purchasing equipment while still struggling to deliver the service for which that equipment was purchased.
Procurement is an event. Equipment management is a lifecycle.
Public procurement understandably concentrates attention on specifications, tendering, technical evaluation, price discovery and contracting. These are essential safeguards.
But the life of medical equipment extends far beyond the procurement process.
A more useful way to think about equipment is as a continuum:
Need → Planning → Specification → Procurement → Installation → Commissioning → Training → Utilisation → Maintenance → Performance Monitoring → Replacement
Weakness at any point can compromise the entire investment.
A technically excellent machine that cannot be maintained locally may perform poorly. An analyser without assured reagents may remain idle. Imaging equipment installed without adequate electrical or structural readiness may experience delays. A device that is available but poorly utilised may add little value to patients.
The objective, therefore, should not simply be successful procurement. It should be sustained service availability.
Start with the health-service need, not the machine
Equipment planning should begin with a clinical and public-health question:
What service are we trying to provide, to whom, at what level of the health system and at what expected workload?
Only after answering that question should the technology solution be defined.
Specifications consequently need to reflect more than technical performance. They should consider the environment in which the equipment will operate: infrastructure, expected workload, human resources, consumables, connectivity, infection-control requirements, maintenance capability and compatibility with existing systems.
This approach changes procurement from purchasing an isolated product into designing a functioning service.
Acquisition price is only one part of cost
Price is important in public procurement, but acquisition cost alone provides an incomplete picture of value.
Medical equipment can generate substantial expenditure throughout its useful life through consumables, reagents, preventive maintenance, breakdown repairs, spare parts, software, calibration and other operating requirements.
A lower purchase price can therefore coexist with a higher lifecycle cost—or with poorer availability.
Procurement systems should preserve transparency and competition while ensuring that specifications, contractual requirements and evaluation frameworks adequately protect the health system against avoidable downstream costs and performance risks.
The goal is not merely to buy economically. It is to obtain reliable clinical capability at responsible lifecycle cost.
Commissioning should begin accountability, not end procurement
Installation is often treated as the final milestone of an equipment purchase. Operationally, it should be closer to the beginning.
Before equipment enters routine service, commissioning should establish that the system has been correctly installed, required infrastructure is available, essential accessories are supplied, appropriate testing has been completed and users have received the necessary training.
This is also the point at which responsibility for subsequent performance should become explicit.
- Who monitors uptime?
- Who responds to breakdowns?
- What is the expected service response time?
- Are preventive-maintenance schedules being followed?
- Are users adequately trained?
- Are consumables continuously available?
Unless these questions have clear answers, an installed machine can quickly become an unavailable service.
Move from asset registers to management intelligence
Digital equipment inventories are valuable, but knowing that a machine exists is only the first level of information.
A mature Biomedical Equipment Management System should progressively help decision-makers understand:
- where equipment is located and whether it is functional;
- utilisation and downtime;
- preventive-maintenance compliance;
- frequency and nature of breakdowns;
- service response and resolution times;
- warranty and contract status;
- maintenance expenditure; and
- equipment approaching replacement.
When these data are analysed rather than merely recorded, equipment management becomes a source of health-system intelligence.
Patterns of repeated failure can influence future specifications. Utilisation data can inform redistribution. Downtime can identify service vulnerabilities. Maintenance history can support replacement decisions.
The feedback loop is important: experience with existing equipment should improve the next procurement cycle.
The most meaningful measure is service availability
Health programmes naturally report inputs and outputs: equipment sanctioned, procured, supplied or installed.
These indicators are useful, but they do not fully describe whether the investment is benefiting patients.
For many technologies, the more meaningful questions are:
- Is the equipment functional when required?
- Is the intended diagnostic or therapeutic service consistently available?
- Is the technology being appropriately utilised?
- Has the investment improved access, quality, efficiency or continuity of care?
This shifts the focus from counting machines to measuring capability.
A laboratory analyser is valuable because it enables dependable testing. An imaging system matters because it enables timely diagnosis. A critical-care device matters because it supports clinical care when needed.
The equipment is the means. The health service is the outcome.
From equipment procurement to equipment governance
Medical technology is becoming more sophisticated, interconnected and central to modern healthcare. Managing it therefore requires coordination across procurement, engineering, clinical services, laboratories, finance, infrastructure, information systems and programme management.
That makes biomedical equipment management more than a procurement function. It is a health-system governance function.
The transition required is conceptually simple but operationally important:
from purchasing equipment to ensuring performance;
from maintaining inventories to managing lifecycles;
from counting installations to measuring availability;
and from managing machines as assets to managing them as components of clinical services.
Procurement remains fundamental. But ultimately, the success of a medical-equipment investment is demonstrated not when a purchase order is issued or a machine is installed.
It is demonstrated when the technology reliably delivers the service for which the health system invested in it.